AG
PMVP icon

Algert Global’s PMV Pharmaceuticals PMVP Stock Holding History

Algert Global’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.4K Sell
39,853
-1,737
-4% -$2.23K ﹤0.01% 1233
2026
Q1 		$51.6K Sell
41,590
-20,430
-33% -$26K ﹤0.01% 1131
2025
Q4 		$77.5K Hold
62,020
– – ﹤0.01% 1102
2025
Q3 		$86.8K Buy
+62,020
New +$85.8K ﹤0.01% 1092
2024
Q3 		– Sell
-15,130
Closed -$24.5K – 1493
2024
Q2 		$24.5K Hold
15,130
– – ﹤0.01% 1472
2024
Q1 		$25.7K Sell
15,130
-16,970
-53% -$31.7K ﹤0.01% 1046
2023
Q4 		$99.5K Buy
32,100
+4,310
+16% +$11.4K ﹤0.01% 1074
2023
Q3 		$171K Buy
+27,790
New +$191K 0.01% 982

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Algert Global's PMVP Position: Q2 2026 in Review

Algert Global reduced its PMV Pharmaceuticals (PMVP) stake by 4.2% in Q2 2026, selling an estimated $2.23K and leaving 39,853 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Algert Global first reported a position in PMVP in Q3 2023 and has held it in 8 quarters since. The position peaked at $171K in Q3 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Algert Global held 39,853 shares of PMV Pharmaceuticals worth $53.4K as of Q2 2026.
  • Algert Global sold 1,737 PMV Pharmaceuticals shares in Q2 2026, an estimated $2.23K.
  • PMV Pharmaceuticals made up ﹤0.01% of Algert Global's portfolio in Q2 2026, its #1233 holding.
  • Algert Global first reported a position in PMV Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
  • Algert Global's PMV Pharmaceuticals position peaked at $171K in Q3 2023.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.